Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 33

1.

Screening trials are even more difficult than we thought they were.

Juffs HG, Tannock IF.

J Natl Cancer Inst. 2002 Feb 6;94(3):156-7. No abstract available.

PMID:
11830599
2.

Overdiagnosis in cancer.

Welch HG, Black WC.

J Natl Cancer Inst. 2010 May 5;102(9):605-13. doi: 10.1093/jnci/djq099. Epub 2010 Apr 22. Review.

PMID:
20413742
3.

Epidemiologic approach for cancer screening. Problems in design and analysis of trials.

Prorok PC.

Am J Pediatr Hematol Oncol. 1992 May;14(2):117-28. Review.

PMID:
1530116
4.

Cancer trends in the United States--a view from Europe.

Quinn MJ.

J Natl Cancer Inst. 2003 Sep 3;95(17):1258-61. Review. No abstract available.

PMID:
12953072
5.

Benefits and risks of screening mammography for women in their forties: a statistical appraisal.

Berry DA.

J Natl Cancer Inst. 1998 Oct 7;90(19):1431-9. Review. No abstract available.

PMID:
9776408
6.

[Screening for cancer].

Caicoya Gómez-Morán M.

Aten Primaria. 1995 Oct 31;16(7):441-4, 446-52. Review. Spanish. No abstract available.

PMID:
7495955
7.

On the efficacy of screening for breast cancer.

Freedman DA, Petitti DB, Robins JM.

Int J Epidemiol. 2004 Feb;33(1):43-55. Review.

PMID:
15075144
8.

The rationale for the ERSPC trial: will it improve the knowledge base on prostate cancer screening?

Auvinen A, Hugosson J.

BJU Int. 2003 Dec;92 Suppl 2:14-6. Review. No abstract available.

9.

Annual report to the nation on the status of cancer, 1975-2000, featuring the uses of surveillance data for cancer prevention and control.

Weir HK, Thun MJ, Hankey BF, Ries LA, Howe HL, Wingo PA, Jemal A, Ward E, Anderson RN, Edwards BK.

J Natl Cancer Inst. 2003 Sep 3;95(17):1276-99. Review. Erratum in: J Natl Cancer Inst. 2003 Nov 5;95(21):1641.

PMID:
12953083
11.

Mammographic screening: a key factor in the control of breast cancer.

Tabár L, Smith RA, Vitak B, Yen MF, Chen TH, Warwick J, Myles JP, Duffy SW.

Cancer J. 2003 Jan-Feb;9(1):15-27. Review. No abstract available.

PMID:
12602763
12.

Current situation of screening for cancer.

Boyle P.

Ann Oncol. 2002;13 Suppl 4:189-98. Review. No abstract available.

PMID:
12401689
13.

Screening mammography in women 40 to 49 years of age: yes.

Kopans DB.

Important Adv Oncol. 1995:231-41. Review. No abstract available.

PMID:
7672809
14.

Evaluation of screening for a cancer: annotated catechism of the Gold Standard creed.

Miettinen OS, Yankelevitz DF, Henschke CI.

J Eval Clin Pract. 2003 May;9(2):145-50. Review.

PMID:
12787177
15.

The story of the European Randomized Study of Screening for Prostate Cancer.

Schröder FH, Denis LJ, Roobol M, Nelen V, Auvinen A, Tammela T, Villers A, Rebillard X, Ciatto S, Zappa M, Berenguer A, Paez A, Hugosson J, Lodding P, Recker F, Kwiatkowski M, Kirkels WJ; ERSPC.

BJU Int. 2003 Dec;92 Suppl 2:1-13. Review. No abstract available.

16.

Novel guidelines for organ donor cancer screening.

Hassanain M.

Ann Transplant. 2014 May 20;19:241-7. doi: 10.12659/AOT.890339. Review.

17.

Cancer screening.

Kramer BS, Brawley OW.

Hematol Oncol Clin North Am. 2000 Aug;14(4):831-48. Review.

PMID:
10949776
18.

Evaluating the correlation between film mammography and MRI for screening women with increased breast cancer risk.

Lee JM, Halpern EF, Rafferty EA, Gazelle GS.

Acad Radiol. 2009 Nov;16(11):1323-8. doi: 10.1016/j.acra.2009.05.011. Epub 2009 Jul 25. Review.

19.

Screening for breast cancer -is there an alternative to mammography?

Miller AB.

Asian Pac J Cancer Prev. 2005 Jan-Mar;6(1):83-6. Review.

20.

[Screening for cancer: what's new?].

Sasco AJ.

Bull Cancer. 2000 Mar;87(3):239-43. Review. French.

Supplemental Content

Support Center